Stephen Lam Selected Research

Chemoprevention

1/2019	Prevention and Early Detection for NSCLC: Advances in Thoracic Oncology 2018.
9/2017	Detecting the Presence and Progression of Premalignant Lung Lesions via Airway Gene Expression.
9/2013	Probability of cancer in pulmonary nodules detected on first screening CT.
5/2013	Chemoprevention of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.
3/2013	Randomized phase II trial of sulindac for lung cancer chemoprevention.
4/2010	Airway PI3K pathway activation is an early and reversible event in lung cancer development.
9/2008	Surfactant protein D and bronchial dysplasia in smokers at high risk of lung cancer.
4/2008	In vivo optical coherence tomography imaging of preinvasive bronchial lesions.
8/2006	A phase I study of myo-inositol for lung cancer chemoprevention.
7/2006	Early detection and chemoprevention of lung cancer.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stephen Lam Research Topics

Disease

77	Lung Neoplasms (Lung Cancer) 10/2022 - 07/2002
59	Neoplasms (Cancer) 10/2022 - 10/2002
23	Chronic Obstructive Pulmonary Disease (COPD) 06/2022 - 08/2009
12	Carcinogenesis 01/2022 - 12/2003
9	Adenocarcinoma of Lung 01/2020 - 01/2012
8	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2021 - 07/2003
7	Inflammation (Inflammations) 06/2022 - 03/2006
6	Squamous Cell Carcinoma (Epidermoid Carcinoma) 09/2014 - 07/2006
4	Infections 05/2022 - 11/2002
4	Adenocarcinoma 01/2019 - 07/2006
3	Emphysema 10/2017 - 08/2009
3	Carcinoma in Situ 03/2016 - 01/2007
3	Asthma (Bronchial Asthma) 09/2015 - 05/2006
2	Pneumonia (Pneumonitis) 05/2022 - 10/2013
2	Genetic Predisposition to Disease (Genetic Predisposition) 01/2017 - 07/2005
2	Small Cell Carcinoma 01/2017 - 07/2006
2	Neoplasm Metastasis (Metastasis) 10/2016 - 02/2013
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 09/2011 - 08/2009
2	Carcinoma (Carcinomatosis) 01/2011 - 07/2006
2	Hyperplasia 03/2010 - 12/2003
2	Metaplasia 03/2010 - 12/2003
1	Eosinophilia 06/2022
1	Lung Diseases (Lung Disease) 01/2022
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2022
1	Crohn Disease (Crohn's Disease) 06/2021
1	Hernia (Hernias) 06/2021
1	Abdominal Pain (Pain, Abdominal) 06/2021
1	Type IV Ehlers-Danlos Syndrome 06/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019
1	Huntington Disease (Huntington's Disease) 01/2019
1	HIV Infections (HIV Infection) 01/2018
1	Obesity 01/2017

Drug/Important Bio-Agent (IBA)

23	Biomarkers (Surrogate Marker)IBA 10/2022 - 01/2005
16	Proteins (Proteins, Gene)FDA Link 10/2022 - 12/2003
9	SmokeIBA 01/2018 - 07/2006
8	MicroRNAs (MicroRNA)IBA 01/2019 - 03/2010
7	Biological ProductsIBA 04/2021 - 03/2010
7	DNA (Deoxyribonucleic Acid)IBA 11/2015 - 03/2006
6	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2022 - 01/2009
5	ArsenicIBA 11/2013 - 01/2011
5	Pharmaceutical PreparationsIBA 03/2012 - 06/2006
4	IgA receptor (protein B)IBA 10/2022 - 01/2013
4	Surface-Active Agents (Surfactants)IBA 10/2022 - 01/2013
4	AntigensIBA 10/2022 - 07/2011
4	Fluticasone (Cutivate)FDA LinkGeneric 05/2022 - 05/2013
4	Budesonide (Pulmicort)FDA LinkGeneric 05/2022 - 10/2004
4	CarcinogensIBA 01/2022 - 11/2012
4	Messenger RNA (mRNA)IBA 10/2017 - 10/2011
3	Formoterol Fumarate (Oxis)FDA Link 05/2022 - 01/2013
3	RadonIBA 01/2022 - 11/2012
3	Inositol (Myoinositol)IBA 12/2016 - 08/2006
3	AutoantibodiesIBA 10/2013 - 07/2011
2	SteroidsIBA 05/2022 - 06/2021
2	Tobacco Smoke Pollution (Passive Smoking)IBA 01/2022 - 11/2021
2	GoldIBA 01/2020 - 09/2014
2	Transcription Factors (Transcription Factor)IBA 11/2019 - 10/2016
2	Carrier Proteins (Binding Protein)IBA 01/2019 - 07/2012
2	Phosphotransferases (Kinase)IBA 10/2017 - 11/2015
2	Volatile Organic CompoundsIBA 08/2015 - 09/2014
2	NF-kappa B (NF-kB)IBA 09/2011 - 05/2004
2	Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA 11/2010 - 09/2008
2	Capsules (Microcapsules)IBA 03/2010 - 07/2006
2	Histones (Histone)IBA 03/2010 - 08/2003
1	Keratin-19 (Keratin 19)IBA 10/2022
1	Carcinoembryonic AntigenIBA 10/2022
1	insulin receptor-related receptor (IRR)IBA 06/2022
1	fluticasone-formoterolIBA 05/2022
1	Salmeterol Xinafoate (Serevent)FDA Link 05/2022
1	Environmental Pollutants (Pollutants, Environmental)IBA 01/2022
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 01/2022
1	CytokinesIBA 01/2022
1	GuanineIBA 01/2022
1	CytosineIBA 01/2022
1	adenovirus receptorIBA 01/2022
1	Indicators and Reagents (Reagents)IBA 01/2022
1	ChemokinesIBA 01/2022
1	Air Pollutants (Pollutants, Air)IBA 11/2021
1	ORALIT (ORS)IBA 01/2021
1	HLA-A Antigens (HLA-A)IBA 01/2020
1	B7-H1 AntigenIBA 10/2019
1	ElementsIBA 01/2019
1	Deoxyribonuclease I (Nickase)IBA 01/2019
1	Complex MixturesIBA 01/2019
1	Adaptor Protein Complex gamma SubunitsIBA 01/2019
1	UraniumIBA 11/2018
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2018
1	LigandsIBA 01/2018
1	Peptides (Polypeptides)IBA 01/2018
1	LDL CholesterolIBA 01/2017

Therapy/Procedure

21	Therapeutics 06/2022 - 10/2002
17	Chemoprevention 01/2019 - 07/2002
6	Drug Therapy (Chemotherapy) 11/2015 - 01/2009
5	Immunotherapy 01/2022 - 01/2016
2	Bronchial Thermoplasty 09/2015 - 05/2006
1	Aftercare (After-Treatment) 05/2022
1	Ileostomy 06/2021
1	Cholecystectomy 06/2021
1	Neoadjuvant Therapy 01/2019
1	Esophagectomy 01/2019
1	Complementary Therapies (Alternative Medicine) 12/2017